Telemonitoring: An opportunity in cystic fibrosis lung transplant recipients

IntroductionTelemedicine has been successfully employed in a wide range of conditions, such as chronic lung disease and COVID-19. This study evaluate the role telemonitoring for early diagnosis acute allograft dysfunction cystic fibrosis adults who underwent transplant (LuTx). Quality life functional level achieved during 12 months follow up were assessed.MethodsPatients randomized into two groups; control group received traditional hospital-based follow-up, whereas patients intervention received, on top standard care, device, with pulse oximeter spirometer integrated. Telemonitoring data digitally transmitted to our centre.ResultsSixteen enrolled each group. No statistically significant difference was found between groups terms incidence dysfunction, time from onset symptoms occurrence LuTx. Moreover, both similar quality level. With reference group: 1) hospital reported consistent those being remotely registered; 2) adherence decreased up; 3) majority high degree satisfaction.ConclusionThe COVID19 pandemic highlighted necessity investigate alternative practices treat chronically ill individuals. is valuable tool improve care LuTx recipients.